Basic Information
LncRNA/CircRNA Name | MALAT1 |
Synonyms | NA |
Region | GRCh38_11:65497688-65506516 |
Ensemble | ENSG00000251562 |
Refseq | NR_002819 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | ||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | retinoblastoma |
ICD-0-3 | C69.2 |
Methods | qPCR, Western blot, Luciferase reporter assay etc |
Sample | RB tissue ,RB cell lines(ARPE-19, HXO-RB44,WERI-RB-1, SO-RB50 and Y79,ARPE-19) |
Expression Pattern | up-regulated |
Function Description | Both RB tissues and cells showed highly expressed MALAT1. When MALAT1 was downregulated, RB cell proliferation was hindered and apoptosis was accelerated. MALAT1 sponged miR-20b-5p and upregulated STAT3. |
Pubmed ID | 32336590 |
Year | 2020 |
Title | Long non-coding RNA MALAT1 aggravates human retinoblastoma by sponging miR-20b-5p to upregulate STAT3. |
External Links
Links for MALAT1 | GenBank HGNC NONCODE |
Links for retinoblastoma | OMIM COSMIC |